Trump’s Surprise Pivot on the Epstein Files, and Why Crypto A.T.M.s Are a Hub for Scams
Plus, Hollywood’s star-studded movies are tanking.Read More
The ‘Donroe Doctrine’: Trump’s Bid to Control the Western Hemisphere
President Trump has tightened the U.S. grip on the Americas by rewarding allies and punishing rivals. That has upended the region’s politics.Read More
How to Not Get Kidnapped for Your Bitcoin
Escaping zipties, hiring bodyguards and other practical lessons in self-defense for crypto traders, after a series of gruesome crimes spooked the community.Read More
How Fraudsters Use Cryptocurrency A.T.M.s to Target Victims
The kiosks, which resemble conventional A.T.M.s and convert cash into virtual currencies, are increasingly under scrutiny as a tool for scammers.Read More
The Crypto Industry’s $28 Billion in ‘Dirty Money’
As President Trump has championed crypto and the industry has gone mainstream, funds from scammers and other criminal groups have flowed onto major crypto exchanges.Read More
New International Student Enrollment Plummeted This Fall, Survey Finds
The overall number of international students enrolled in U.S. colleges and universities, including those who enrolled in prior years or who are working after graduation, fell only slightly.Read More
Trump Says House Republicans Should Vote to Release Epstein Files
President Trump reversed himself as he faced the prospect that dozens of Republicans could vote this week to compel his administration to release files related to Jeffrey Epstein.Read More
Latest U.S. Strike on Boat in Pacific Kills 3, Southern Command Says
The United States has carried out at least 21 strikes on boats the Trump administration accuses of smuggling drugs, killing at least 83 people.Read More
At Catholic Churches, Trump’s Immigration Crackdown Takes Center Stage
Immigration was on the minds of priests and parishioners following a letter from the nation’s Catholic bishops decrying how immigrants are being treated.Read More
A Pill for Women’s Libido Meets a Cultural Moment
A decade ago, Cindy Eckert struggled to convince skeptics about a drug for premenopausal women. Lately, her business is booming.Read More